Stay updated on Open-Label Safety Study of AXS-05 in Depression Clinical Trial
Sign up to get notified when there's something new on the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page.

Latest updates to the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes regarding the study of AXS-05 for Major Depressive Disorder, with the removal of detailed descriptions of a long-term safety study and its inclusion/exclusion criteria.SummaryDifference8%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Open-Label Safety Study of AXS-05 in Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Open-Label Safety Study of AXS-05 in Depression Clinical Trial page.